Management of salivary flow in head and neck cancer patients - A systematic review

被引:35
作者
Bomeli, Steven R. [1 ]
Desai, Shaun C. [2 ]
Johnson, Jonas T. [1 ]
Walvekar, Rohan R. [1 ]
机构
[1] Univ Pittsburgh, Dept Otolaryngol & Head Neck Surg, Pittsburgh, PA 15213 USA
[2] George Washington Univ, Sch Med, Washington, DC USA
关键词
Sialorrhea; Saliva; Sialocele; Head and neck cancer; Drooling; Botulinum;
D O I
10.1016/j.oraloncology.2008.02.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Altered salivary flow is frequently observed as a result of head and neck cancer (HNC) treatment. Decreased salivation or xerostomia consequent to radiation therapy is the most frequently observed complication resulting in patient discomfort, tooth decay, periodontal disease, and dysphagia. Excessive salivary flow or sialorrhea can be equally troublesome to the patient and their caregivers. It is caused by tumor or treatment-related dysphagia, or due to altered anatomy from oncologic resections of the upper aerodigestive tract, especially the middle third of the mandible. Post-operative sialocetes and fistulas are other manifestations of abnormal salivary flow which interfere with wound heating. The management of excessive salivary flow in HNC patients is a less frequently discussed subject in medical. literature. Complications related to salivary flow can cause increased morbidity and occasionally mortality related to HNC treatment. Consequently, the management of excessive salivary flow in the post-operative setting and for palliation has a great impact on overall outcome of surgical intervention and quality of life for the patient. Excessive salivary flow can be treated with aggressive wound care, pharmacologic inhibition, radiation, or surgery. A review of the literature focused on the management of excessive salivary flow in HNC patients is presented. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1000 / 1008
页数:9
相关论文
共 79 条
[1]   External radiation of the parotid glands significantly reduces drooling in patients with motor neurone disease with bulbar paresis [J].
Andersen, PM ;
Grönberg, H ;
Franzen, L ;
Funegård, U .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2001, 191 (1-2) :111-114
[2]  
ARNOLD HG, 1977, DEV MED CHILD NEUROL, V19, P509
[3]   Radial forearm free flap pharyngoesophageal reconstruction [J].
Azizzadeh, B ;
Yafai, S ;
Rawnsley, JD ;
Abemayor, E ;
Sercarz, JA ;
Calcaterra, TC ;
Berke, GS ;
Blackwell, KE .
LARYNGOSCOPE, 2001, 111 (05) :807-810
[4]   Use of glycopyrrolate and other anticholinergic medications for sialorrhea in children with cerebral palsy [J].
Bachrach, SJ ;
Walter, RS ;
Trzcinski, K .
CLINICAL PEDIATRICS, 1998, 37 (08) :485-490
[5]   ADENOCARCINOMA OF THE TONGUE COMPLICATED BY A HEMIMANDIBULECTOMY - SOFT-TISSUE SUPPORT FOR A TONGUE PROSTHESIS IN AN EDENTULOUS GLOSSECTOMY PATIENT [J].
BALLARD, JL ;
KERNER, E ;
TYSON, J ;
ASHFORD, J ;
REES, R .
JOURNAL OF PROSTHETIC DENTISTRY, 1986, 56 (04) :470-473
[6]   SUCTION DRAIN MANAGEMENT OF SALIVARY FISTULAS [J].
BASTIAN, RW ;
PARK, AH .
LARYNGOSCOPE, 1995, 105 (12) :1337-1341
[7]   Expanding use of botulinum toxin [J].
Bhidayasiri, R ;
Truong, DD .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 235 (1-2) :1-9
[8]   Botulinum toxin: Basic science and clinical uses in otolaryngology [J].
Blitzer, A ;
Sulica, L .
LARYNGOSCOPE, 2001, 111 (02) :218-226
[9]   Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia [J].
Brashear, A ;
Lew, MF ;
Dykstra, DD ;
Comella, CL ;
Factor, SA ;
Rodnitzky, RL ;
Trosch, R ;
Singer, C ;
Brin, MF ;
Murray, JJ ;
Wallace, JD ;
Willmer-Hulme, A ;
Koller, M .
NEUROLOGY, 1999, 53 (07) :1439-1446
[10]   Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia [J].
Brin, MF ;
Lew, MF ;
Adler, CH ;
Comella, CL ;
Factor, SA ;
Jankovic, J ;
O'Brien, C ;
Murray, JJ ;
Wallace, JD ;
Willmer-Hulme, A ;
Koller, M .
NEUROLOGY, 1999, 53 (07) :1431-1438